Sonia Alonso
Overview
Explore the profile of Sonia Alonso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pose E, Jimenez C, Zaccherini G, Campion D, Piano S, Uschner F, et al.
JAMA
. 2025 Feb;
333(10):864-874.
PMID: 39908052
Importance: There are no useful treatments to prevent the development of severe complications of liver cirrhosis. Simvastatin and rifaximin have shown beneficial effects in liver cirrhosis. Objective: To assess whether...
2.
Juanola A, Ma A, de Wit K, Gananandan K, Roux O, Zaccherini G, et al.
Gut
. 2023 Oct;
73(1):156-165.
PMID: 37884354
Background: Patients with decompensated cirrhosis experience high mortality rates. Current prognostic scores, including the model for end-stage liver disease (MELD), may underperform in settings other than in those they were...
3.
Romero-Cristobal M, Clemente-Sanchez A, Ramon E, Tellez L, Canales E, Ortega-Lobete O, et al.
JHEP Rep
. 2023 Jan;
5(3):100645.
PMID: 36691569
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natural history of cirrhosis, influencing clinical decisions in patients with hepatocellular carcinoma (HCC). Previous small series suggested...
4.
Romero-Cristobal M, Clemente-Sanchez A, Peligros M, Ramon E, Matilla A, Colon A, et al.
United European Gastroenterol J
. 2022 Sep;
10(8):805-816.
PMID: 36065767
Objective: Cirrhosis is characterized by the complex interplay among biological, histological and haemodynamic events. Liver and spleen remodelling occur throughout its natural history, but the prognostic role of these volumetric...
5.
Lama C, Parada C, Alonso S
Gastroenterol Hepatol
. 2021 Aug;
45 Suppl 1:45-46.
PMID: 34400192
No abstract available.
6.
Purti E, Ingles J, De la Pena L, Rodriguez M, Puiggene M, Bernad M, et al.
Arch Prev Riesgos Labor
. 2020 Apr;
23(2):146-153.
PMID: 32320539
No abstract available.
7.
Alonso S, Guerra A, Carreira L, Ferrer J, Gutierrez M, Fernandez-Rodriguez C
BMC Gastroenterol
. 2017 Dec;
17(1):168.
PMID: 29268704
Background: Hepatitis B virus (HBV) chronic infection affects up to 240 million people in the world and it is a common cause of cirrhosis and hepatocellular carcinoma (HCC). HBV covalently...
8.
Blasco-Algora S, Masegosa-Ataz J, Alonso S, Gutierrez M, Fernandez-Rodriguez C
BMJ Open Gastroenterol
. 2017 Jan;
3(1):e000104.
PMID: 28074149
Introduction: Non-selective β-blockers (NSBBs) are widely prescribed in patients with cirrhosis for primary and secondary prophylaxis of bleeding oesophageal varices. Furthermore, it has been suggested that the clinical benefits of...
9.
van der Meer A, Feld J, Hofer H, Almasio P, Calvaruso V, Fernandez-Rodriguez C, et al.
J Hepatol
. 2016 Oct;
66(3):485-493.
PMID: 27780714
Background & Aims: The risk of hepatocellular carcinoma (HCC) is reduced but not eradicated among patients with hepatitis C virus (HCV)-induced advanced hepatic fibrosis who attained sustained viral response (SVR)....
10.
Oliva-Moreno J, Pena-Longobardo L, Alonso S, Fernandez-Bolanos A, Luisa Gutierrez M, Hidalgo-Vega A, et al.
Eur J Gastroenterol Hepatol
. 2015 Apr;
27(6):631-7.
PMID: 25853930
Background And Aims: Hepatitis C virus (HCV) infection places a huge burden on healthcare systems. There is no study assessing the impact of HCV infection on premature deaths in Spain....